SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Ranking of the Best US Hospitals for Psychiatric Care.

2.

Screening for prostate cancer: is it time to give up digital rectal examination?

3.

US Counties Suffered Significantly from a Lack of Psychiatric Care.

4.

Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

5.

According to a study, taking part in a clinical trial for cancer may not actually increase survival.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot